Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
V. Horn, C. Cancino, L. Steinheuer, B. Obermayer, K. Fritz, A. L. Nguyen, C. Plattner, D. Boesel, M. Burns, A. R. Schulz, E. Mantzivi, D. Lissner, T. Conrad, M.-F. Mashreghi, E. Sonnenberg, , A. N. Hegazy
bioRxiv · Oct 1, 2023Immunology
S. Salcher, I. Heidegger, G. Untergasser, G. Fotakis, A. Scheiber, A. Martowicz, A. Noureen, A. Krogsdam, C. Schatz, G. Schafer, Z. Trajanoski, D. Wolf, S. Sopper, A. Pircher
This study compares two scRNA-seq platforms, finding differences in cell population abundance and mRNA quantification, guiding platform selection and data interpretation.
bioRxiv · Jul 3, 2023Cancer Biology
A. Kirchmair, N. Nemati, G. Lamberti, M. P. Trefny, A. Krogsdam, A. Siller, P. Hörtnagl, P. Schumacher, S. Sopper, A. M. Sandbichler, A. Zippelius, B. Ghesquiere, Z. Trajanoski
This study uses 13C metabolomics and transcriptomics to analyze metabolic changes in CD8+ T cells during differentiation, identifying key metabolic checkpoints and their role in exhaustion.
bioRxiv · May 18, 2023 · PreprintImmunology
C. Plattner, G. Lamberti, P. Blattmann, A. Kirchmair, D. Rieder, Z. Loncova, G. Sturm, S. Scheidl, M. E. Ijsselsteijn, G. Fotakis, A. Noureen, R. Lisandrelli, N. Boeck, N. Nemati, A. Krogsdam, , Z. Trajanoski
The paper uses patient-derived organoids and phosphoproteomics to study signaling crosstalk in colorectal cancer and identify off-target effects of kinase inhibitors.
bioRxiv · Sep 16, 2022Cancer Biology
S. Salcher, G. Sturm, L. Horvath, G. Untergasser, G. Fotakis, E. Panizzolo, A. Martowicz, G. Pall, G. Gamerith, M. Sykora, F. Augustin, K. Schmitz, F. Finotello, D. Rieder, S. Sopper, , Z. Trajanoski
The paper integrates single-cell data to create a high-resolution atlas of NSCLC tumor microenvironments, revealing immune cell diversity, neutrophil plasticity, and associations with treatment outcomes.
bioRxiv · May 9, 2022Cancer Biology